From: Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk
Stage 1 Cutoff
0.1
0.2
0.3
0.4
Power
0.829
0.875
0.859
0.907
False Positive Rate
0.048
0.059
0.053
0.067
Expected # of Tests
3,666,336
4,217,337
4,775,891
5,452,877